LOOMIS SAYLES & CO L P – Blueprint Medicines Corporation Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$21.46M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.20% | -3.94K shares | 4.81M | $65.89 | 325.81K |
| Q2 2022 | share | Decrease | -24.72% | -108.26K shares | -11.32M | $50.51 | 329.76K |
| Q1 2022 | share | Increase | +15.54% | 58.92K shares | -12.62M | $63.88 | 438.02K |
| Q4 2021 | share | Decrease | -2.63% | -10.22K shares | 578K | $109.45 | 379.09K |
| Q3 2021 | share | Decrease | -1.53% | -6.04K shares | 5.25M | $102.81 | 389.32K |
| Q2 2021 | share | Decrease | -1.99% | -8.03K shares | -4.44M | $87.96 | 395.36K |
| Q1 2021 | share | Increase | +13.51% | 48.01K shares | -634K | $97.23 | 403.40K |
| Q4 2020 | share | Decrease | -0.59% | -2.09K shares | 6.71M | $112.15 | 355.39K |
| Q3 2020 | share | Increase | +15.62% | 48.28K shares | 9.02M | $92.7 | 357.48K |
| Q2 2020 | share | Increase | 0.00% | 309.19K shares | 24.11M | $78 | 309.19K |
| Q1 2020 | share | Decrease | -100.00% | -426.97K shares | -34.20M | $58.48 | 0 |
| Q4 2019 | share | Decrease | -2.80% | -12.30K shares | 1.93M | $80.11 | 426.97K |
| Q3 2019 | share | Increase | +17.06% | 64.01K shares | -3.12M | $73.47 | 439.28K |
| Q2 2019 | share | Increase | +1.21% | 4.50K shares | 5.71M | $94.33 | 375.26K |
| Q1 2019 | share | Increase | +3.74% | 13.37K shares | 10.41M | $80.05 | 370.76K |
| Q4 2018 | share | Increase | +324.19% | 273.14K shares | 12.69M | $53.91 | 357.39K |
| Q3 2018 | share | Increase | 0.00% | 84.25K shares | 6.57M | $78.06 | 84.25K |